Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$51.36
+2.2%
$52.46
$43.38
$62.88
$6.95B1.111.11 million shs1.82 million shs
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
$155.96
$155.74
$93.34
$156.22
$10.30B0.55656,912 shsN/A
Insulet Co. stock logo
PODD
Insulet
$184.28
+4.5%
$169.73
$125.82
$331.65
$12.90B1848,261 shs1.06 million shs
Teleflex Incorporated stock logo
TFX
Teleflex
$201.52
+0.3%
$216.73
$177.63
$262.97
$9.49B1.13285,820 shs374,466 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
-3.23%-0.67%-3.01%-4.65%-13.99%
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
0.00%0.00%0.00%0.00%0.00%
Insulet Co. stock logo
PODD
Insulet
+1.13%+3.61%+6.91%-11.64%-46.34%
Teleflex Incorporated stock logo
TFX
Teleflex
-1.01%-3.61%-7.29%-20.33%-22.09%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.8827 of 5 stars
3.32.00.04.13.14.23.1
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
2.1859 of 5 stars
0.00.01.73.80.61.72.5
Insulet Co. stock logo
PODD
Insulet
4.9305 of 5 stars
3.45.00.04.93.30.83.1
Teleflex Incorporated stock logo
TFX
Teleflex
4.9347 of 5 stars
3.35.01.73.92.52.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.67
Moderate Buy$66.3329.15% Upside
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
N/AN/AN/AN/A
Insulet Co. stock logo
PODD
Insulet
2.80
Moderate Buy$240.3330.42% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.67
Moderate Buy$261.7529.89% Upside

Current Analyst Ratings

Latest HRC, TFX, PODD, and GMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2024
Insulet Co. stock logo
PODD
Insulet
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$200.00
5/3/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$240.00 ➝ $219.00
5/3/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/18/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00
2/26/2024
Insulet Co. stock logo
PODD
Insulet
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$214.00 ➝ $213.00
2/23/2024
Insulet Co. stock logo
PODD
Insulet
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$250.00 ➝ $230.00
2/23/2024
Insulet Co. stock logo
PODD
Insulet
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$190.00 ➝ $225.00
2/23/2024
Teleflex Incorporated stock logo
TFX
Teleflex
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$285.00
2/23/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$272.00 ➝ $265.00
2/23/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$270.00 ➝ $265.00
2/21/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$58.00 ➝ $60.00
(Data available from 5/7/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.02B6.81$3.57 per share14.40$29.32 per share1.75
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
$3.02B3.41$9.29 per share16.79$28.56 per share5.46
Insulet Co. stock logo
PODD
Insulet
$1.70B7.60$4.01 per share45.96$10.49 per share17.57
Teleflex Incorporated stock logo
TFX
Teleflex
$2.97B3.19$18.69 per share10.78$94.49 per share2.13

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.1743.9015.661.537.83%8.82%7.20%5/7/2024 (Confirmed)
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
$248.50M$3.7241.9221.72N/A8.23%23.07%8.96%N/A
Insulet Co. stock logo
PODD
Insulet
$206.30M$2.9163.3347.623.1412.16%32.19%7.93%5/9/2024 (Confirmed)
Teleflex Incorporated stock logo
TFX
Teleflex
$356.33M$6.2332.3513.271.959.82%14.78%8.79%8/1/2024 (Estimated)

Latest HRC, TFX, PODD, and GMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Insulet Co. stock logo
PODD
Insulet
$0.39N/A-$0.39N/AN/AN/A  
5/7/2024N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.55$0.72+$0.17N/A$586.82 million$606.67 million  
5/2/2024Q1 2024
Teleflex Incorporated stock logo
TFX
Teleflex
$3.07$3.21+$0.14$6.10$726.85 million$737.80 million      
2/22/2024Q4 2023
Insulet Co. stock logo
PODD
Insulet
$0.67$1.40+$0.73$1.36$461.26 million$509.80 million    
2/22/2024Q4 23
Teleflex Incorporated stock logo
TFX
Teleflex
$3.26$3.38+$0.12$6.10$769.01 million$773.90 million      
2/20/2024Q4 2023
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
$0.960.62%N/A25.81%N/A
Insulet Co. stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.360.67%N/A21.83%N/A

Latest HRC, TFX, PODD, and GMED Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Quarterly$0.340.68%5/14/20245/15/20246/14/2024
2/22/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Quarterly$0.340.57%2/29/20243/1/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.10
4.88
2.72
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
0.97
1.38
1.05
Insulet Co. stock logo
PODD
Insulet
1.86
3.51
2.62
Teleflex Incorporated stock logo
TFX
Teleflex
0.37
2.51
1.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
76.45%
Insulet Co. stock logo
PODD
Insulet
N/A
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
24.30%
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
0.69%
Insulet Co. stock logo
PODD
Insulet
0.47%
Teleflex Incorporated stock logo
TFX
Teleflex
1.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million102.48 millionOptionable
Hill-Rom Holdings, Inc. stock logo
HRC
Hill-Rom
10,00066.05 million65.59 millionOptionable
Insulet Co. stock logo
PODD
Insulet
3,00070.02 million69.69 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,50047.10 million46.43 millionOptionable

HRC, TFX, PODD, and GMED Headlines

SourceHeadline
Teleflex Incorporated (NYSE:TFX) Plans Quarterly Dividend of $0.34Teleflex Incorporated (NYSE:TFX) Plans Quarterly Dividend of $0.34
marketbeat.com - May 7 at 9:49 AM
Teleflex Incorporated (NYSE:TFX) Shares Acquired by Natixis Advisors L.P.Teleflex Incorporated (NYSE:TFX) Shares Acquired by Natixis Advisors L.P.
marketbeat.com - May 7 at 7:08 AM
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPHOutcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
globenewswire.com - May 7 at 6:30 AM
Unlocking Teleflex (TFX) International Revenues: Trends, Surprises, and ProspectsUnlocking Teleflex (TFX) International Revenues: Trends, Surprises, and Prospects
zacks.com - May 6 at 2:56 PM
Teleflex: Compelling, Despite Some Operational HiccupsTeleflex: Compelling, Despite Some Operational Hiccups
seekingalpha.com - May 6 at 7:13 AM
Teleflex Announces Quarterly DividendTeleflex Announces Quarterly Dividend
globenewswire.com - May 6 at 6:30 AM
New York Life Investment Management LLC Increases Position in Teleflex Incorporated (NYSE:TFX)New York Life Investment Management LLC Increases Position in Teleflex Incorporated (NYSE:TFX)
marketbeat.com - May 6 at 6:08 AM
Teleflex (NYSE:TFX) Rating Reiterated by Needham & Company LLCTeleflex (NYSE:TFX) Rating Reiterated by Needham & Company LLC
americanbankingnews.com - May 5 at 6:46 AM
Teleflex (NYSE:TFX) Price Target Cut to $219.00Teleflex (NYSE:TFX) Price Target Cut to $219.00
americanbankingnews.com - May 5 at 3:46 AM
Teleflex (NYSE:TFX) Posts Quarterly  Earnings Results, Beats Expectations By $0.14 EPSTeleflex (NYSE:TFX) Posts Quarterly Earnings Results, Beats Expectations By $0.14 EPS
marketbeat.com - May 4 at 2:54 PM
Teleflex Incorporated (NYSE:TFX) Q1 2024 Earnings Call TranscriptTeleflex Incorporated (NYSE:TFX) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 3 at 9:01 PM
Teleflex (NYSE:TFX) Updates FY 2024 Earnings GuidanceTeleflex (NYSE:TFX) Updates FY 2024 Earnings Guidance
marketbeat.com - May 3 at 7:23 PM
Teleflex (TFX) Q1 Earnings Beat Estimates, Margins RiseTeleflex (TFX) Q1 Earnings Beat Estimates, Margins Rise
zacks.com - May 3 at 1:16 PM
Teleflex Inc (TFX) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Revenue and ...Teleflex Inc (TFX) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Revenue and ...
finance.yahoo.com - May 3 at 9:32 AM
Teleflex First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsTeleflex First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
finance.yahoo.com - May 3 at 9:32 AM
Teleflex (NYSE:TFX) PT Lowered to $219.00 at Truist FinancialTeleflex (NYSE:TFX) PT Lowered to $219.00 at Truist Financial
marketbeat.com - May 3 at 9:00 AM
Teleflexs (TFX) "Hold" Rating Reiterated at Needham & Company LLCTeleflex's (TFX) "Hold" Rating Reiterated at Needham & Company LLC
marketbeat.com - May 3 at 8:38 AM
How Is The Market Feeling About Teleflex?How Is The Market Feeling About Teleflex?
benzinga.com - May 2 at 4:05 PM
Teleflex beats quarterly profit estimates on healthy demand for medical devicesTeleflex beats quarterly profit estimates on healthy demand for medical devices
reuters.com - May 2 at 11:04 AM
Teleflex Q1 Results Top Estimates: Boosts FY24 Adj. EPS OutlookTeleflex Q1 Results Top Estimates: Boosts FY24 Adj. EPS Outlook
markets.businessinsider.com - May 2 at 11:04 AM
TFX Stock Earnings: Teleflex Beats EPS, Beats Revenue for Q1 2024TFX Stock Earnings: Teleflex Beats EPS, Beats Revenue for Q1 2024
msn.com - May 2 at 11:04 AM
Teleflex Inc (TFX) Q1 Earnings: Adjusted EPS Surpasses Estimates Amidst Revenue GrowthTeleflex Inc (TFX) Q1 Earnings: Adjusted EPS Surpasses Estimates Amidst Revenue Growth
finance.yahoo.com - May 2 at 11:04 AM
Teleflex (NYSE:TFX) Updates FY24 Earnings GuidanceTeleflex (NYSE:TFX) Updates FY24 Earnings Guidance
marketbeat.com - May 2 at 10:38 AM
Compared to Estimates, Teleflex (TFX) Q1 Earnings: A Look at Key MetricsCompared to Estimates, Teleflex (TFX) Q1 Earnings: A Look at Key Metrics
zacks.com - May 2 at 10:36 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Hill-Rom logo

Hill-Rom

NYSE:HRC
Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.
Insulet logo

Insulet

NASDAQ:PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Teleflex logo

Teleflex

NYSE:TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.